Food and Drug Administration this week added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency. Drugs on these lists are intended to address shortages and increase access in the treatment of COVID-19 patients. FDA also this week announced voluntary recalls of two hand sanitizers due to the potential presence of methanol, also known as wood alcohol. Both AAA Cosmética, S.A. de C.V. and 4e Brands North America said they have not received complaints about the products.

Related News Articles

Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…